4248
Z. Yinghuai et al. / Journal of Organometallic Chemistry 692 (2007) 4244–4250
a borolating agent was explored. When 1 and TPy were
mixed, the color of the solution changed smoothly from
red brown into dark green. The product was isolated,
analyzed and its NMR spectra were run. Both spectra
and analysis are consistent with an Ir(–o-O–C6H4–
CH@N–CH2Ph)(cod)(TPy) (3) complex. This suggests a
catalytic cycle shown in Scheme 3. Accordingly, B2pin2
could undergo oxidative addition promoting a loss of
cod, giving the catalytically active species, Ir(–o-O–
C6H4–CH@N–CH2Ph)(TPy)(Bpin)2 (4). It is assumed that
the addition of the B2pin2 would cause the loss of cod a
six coordinate Ir(III) species (4). Alternatively, the cod
could be converted to a monodentate ligand, yielding a
seven coordinate Ir complex. This would be consistent
with the observation of Hartwig and co-workers, that
[IrCl(coe)2]2 is just as good a catalytic precursor than is
[IrCl(cod)]2 [11]. Reaction with an arene to product Ar-
Bpin and the six coordinate (H)Ir(–o-O–C6H4–CH@N–
CH2Ph)(TPy)(Bpin) (5) could easily follow. The C–H acti-
vation could proceed through either an oxidative addi-
tion/reductive elimination involving a seven coordinate
Ir(V) intermediate, or a r-bond metathesis process. Both
processes have been postulate, for Ir-catalyzed borylations
[13,20]. The resulting hydrido complex (5) could then
react with a B2pin2 or HBpin to give (4) and HBpin or
H2, respectively. The cycle could then be repeated. During
the cycle, ionic liquid may play an important role in the
stabilization of intermediates via electrostatic interaction,
which might be crucial in the decomposition step of pro-
posed iridium(V) intermediate to form para-isomers of
boroxines. It should be stressed that Scheme 3 represents
a reasonable sequence of reactions, based on the viability
of compounds 4 and 5, neither one of these proposed
intermediates have been identified. They are similar to
other intermediates proposed for Ir(I)-catalyzed boryla-
tion reactions.
structural modifications of the catalyst is undergoing in
our laboratories.
4. Experimental
General methods. All the operations were carried out
under an argon atmosphere using standard Schlenk tech-
niques or in a glove box. Solvents diethyl ether, dichloro-
methane, toluene, n-hexane and tetrahydrofuran (THF)
were purified by a solvent purification system while ben-
zene was dried with sodium. All other reagents were used
as received. Salicylidenebenzylamine and salicylidenephe-
nylamine were prepared according to literature [19]. Ele-
mental analyses were measured in a CHNS analyzer and
melting points determined by a Buchi melting point ana-
¨
1
lyzer. H, 13C and 11B NMR were recorded on a Bruker
Advance 400 MHz spectrometer. Chemical shifts were
measured in ppm relative to TMS standard (1H:
400.2 MHz, 13C: 100.6 MHz, 11B: 128.4 MHz). Infrared
(IR) spectra were measured using a BIO-RAD spectropho-
tometer with KBr pellets. Rigaku Single Crystal Diffraction
System was used for single crystal X-ray analysis.
4.1. Synthesis of complex Ir(–o-O–C6H4–CH@N–
CH2Ph)(cod) (1)
A 0.15 g (0.71 mmol) of salicylidenebenzylamine was
treated with 0.14 g (3.55 mmol) of NaH (60% in mineral
oil) in 75 ml diethyl ether at room temperature. After 3 h
of stirring at room temperature, the mixture was filtered
to remove unreacted NaH and the resulting solution added
to 0.24 g (0.35 mmol) [IrCl(cod)]2 in 75 ml THF at ꢁ78 °C.
The mixture was kept at that temperature for 30 min and
then allowed to warm to room temperature spontaneously
and continuous stirring for 3 h. After the reaction process,
the solvents were removed under reduced pressure and the
solid was washed with benzene, filtered and dried in high
vacuum to give an orange solid 1 in 82% yield (mp, 151–
153 °C). Single crystal suitable for X-ray diffraction was
obtained from solvents evaporation from a saturated solu-
tion 1 in CH2Cl2/n-hexane. Crystal structure and refine-
ment data are described in Fig. 1 and Table 1. Anal.
Calc. for C22H24IrNO 1: C, 51.71; H, 4.73; N, 2.74. Found:
3. Conclusion
Ir(I) complexes, Ir(–o-O–C6H4–CH@N–CH2Ph)(cod) 1
and Ir(–o-O–C6H4–CH@N–Ph)(cod) 2, have been synthe-
sized by the reaction of the sodium salts of Schiff bases
salicylidenebenzylamine and salicylideneaniline with
[IrCl(cod)]2 and, on activation by bases, used as catalysts
for arylborylation reactions. Of the two precatalysts, 1,
when activated with tetra-2-pyridinylpyrazine (TPy), was
found to be the more active phenylborylation catalyst.
In contrast to 2 and [IrCl(cod)]2, the catalytic perfor-
mance of 1 was enhanced when a solvent mixture of
dichloromethane and the ionic liquid, tributyltetradecyl-
phosphonium dodecylbenzenesulfonate, TBPD, was used.
It was found that compound 1 is also active phenylbory-
lation catalyst using HBpin in the presence of tetra-2-
pyridinylpyrazine (TPy) in a yield of 43%. The different
results found in the two catalytic systems could indicate
that different mechanisms are operating. A more detailed
mechanistic study and an investigation of the effects of
1
C, 51.85; H, 4.43; N, 2.67%. H NMR (CDCl3): d = 1.725
(d, 4H, cod-CH2); 2.233 (t, 4H, cod-CH2); 3.488 (s, 2H,
cod-HC@C); 4.451 (s, 2H, cod-HC@C); 4.840 (s, 2H,
CH2); 6.627–7.495 (m, 9H, Ph-H); 8.291 (s, 1H, N@CH);
13C NMR (CDCl3): d = 29.35 (cod-CH2); 32.66 (cod-
CH2); 54.59 (cod-C@C); 61.78 (CH2); 69.90 (cod-C@C);
115.84–139.21 (Ph-C); 165.44 (Ph-C); 166.30 (N@CH). IR
(KBr pellet, cmꢁ1, vs = very strong, s = strong, m = mid-
dle, w = weak): m = 2998 (w), 2972 (w), 2914 (w), 2879
(w), 2830 (w), 2361 (vs), 2342 (s), 1590 (s), 1536 (s), 1470
(m), 1435 (m), 1406 (m), 1328 (m), 1233 (w), 1199 (w),
1151 (m), 1130 (w), 1077 (w), 1023 (w), 973 (w), 895 (w),
850 (w), 807 (w), 762 (m), 738 (m), 694 (w), 683 (w), 602
(w), 488 (w), 464 (w).